We shouldn’t rush to use an unproven malaria drug to treat the coronavirus

As the pandemic deepens, physicians face an agonizing decision — to medicate or not to medicate?

Here’s the dilemma: Over the past few weeks, some small studies suggested a decades-old malaria drug called hydroxychloroquine may have the potential to combat the novel coronavirus known as Covid-19. And as the results trickled out, the tablet has become more valuable than gold.

Prescriptions and hospital orders jumped, causing shortages. State pharmacy boards, in fact, claimed some doctors were hoarding the medicine for themselves. President Trump touted the tablet by saying he had a “feeling” it would work. The widely watched conservative TV host Laura Ingraham tweeted that one seriously ill patient recovered like “Lazarus” after being given hydroxychloroquine.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In